NEW YORK (TheStreet) -- UBS increased its price target on Cardinal Health (CAH) to $80 from $77 and set a "buy" rating. The firm noted a positive outlook on the fourth-quarter of the fiscal year 2014 after peers reported strong results.
The stock closed at $72.37 on Friday.
Separately, TheStreet Ratings team rates CARDINAL HEALTH INC as a "buy" with a ratings score of B+. TheStreet Ratings Team has this to say about their recommendation:
"We rate CARDINAL HEALTH INC (CAH) a BUY. This is driven by multiple strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its solid stock price performance and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income."
You can view the full analysis from the report here: CAH Ratings ReportCAH data by YCharts